Delivery Order SPE2DB24D1104-SPE2DB25FYCM7
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Abiraterone Acetate 500 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,334.05 and a period of performance through June 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 120 tablets of Abiraterone Acetate 250 mg. The contract has a ceiling value of $33,440.75 and is a Firm Fixed Price Delivery Order with a completion date of June 26, 2025. The contract is not set aside and allows for open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.28, is for the delivery of abiraterone acetate 250 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,733.10, is for the delivery of 4,567,313,202 units of abiraterone acetate 250 mg tablets. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 20, 2025. This contract award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abiraterone Acetate 250 MG tablets in quantities of 120. The $1,353.08 Firm Fixed Price contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,919.54, is for the delivery of Abiraterone Acetate 250 mg tablets. The delivery order has a firm fixed price and a completion date of May 16, 2025. The contract is not set aside and is therefore open to full and open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.20, is for the delivery of abiraterone acetate 250 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Abiraterone Acetate 250 mg tablets, with a total ceiling value of $13,473.62 and a performance period extending through April 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,016.18, is a delivery order for the supply of Abiraterone Acetate 500 mg tablets. It is a firm fixed-price contract with a performance period ending on May 14, 2025. The contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $27,391.67, is for the delivery of 4,567,763 units of the prescription drug Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition....